University of Kansas School of Medicine
Radiation Oncology residency · Kansas City, KS · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Kansas's research in radiation oncology, which the program shares with other departments and affiliated hospitals.
About University of Kansasinstitution-wide radiation oncology research
Radiation Oncology publications from University of Kansas and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
67
works per year
39th of 47 radiation oncology residency programs
+38.4%
2-year growth
2nd of 47 radiation oncology residency programs
20.2%
in top 10% of field (works before 2025)
29th of 47 radiation oncology residency programs
38.3%
cited above world average
33rd of 47 radiation oncology residency programs
Works per year · * 2026 so far
Oncology · 281Radiology, Nuclear Medicine and Imaging · 57
Radiation Oncology research topics at University of Kansas
Papers in the window; each links to the list on OpenAlex.
Most cited at University of Kansas since 2024
All radiation oncology papers there on OpenAlex
- Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myelomaSurbhi Sidana et al. · Blood · 2024 · PubMed · cited 158
- Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial updateMartin H. Dreyling et al. · Blood · 2024 · PubMed · cited 106
- Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysisAmneet Bajwa et al. · Blood Advances · 2024 · PubMed · cited 50
- Screening and Surveillance of Colorectal Cancer: A Review of the LiteratureMarcello Fabio Maida et al. · Cancers · 2024 · PubMed · cited 46
- Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in MyelomaWilliam Wesson et al. · Transplantation and Cellular Therapy · 2024 · PubMed · cited 43
- Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucelNausheen Ahmed et al. · Blood Advances · 2024 · PubMed · cited 41
- Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysisPeter A. Riedell et al. · Blood Advances · 2024 · PubMed · cited 37
- Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myelomaSurbhi Sidana et al. · Blood · 2025 · PubMed · cited 35
- Posoleucel in Kidney Transplant Recipients with BK ViremiaAnil K. Chandraker et al. · Journal of the American Society of Nephrology · 2024 · PubMed · cited 32
- Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell LymphomaRoni Shouval et al. · Transplantation and Cellular Therapy · 2025 · PubMed · cited 29